Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
China Traditional Chinese Medicine (570 HK)
Watchlist
307
Analysis
Health Care
•
Hong Kong
China Traditional Chinese Medicine Co. Limited, through its subsidiaries, manufactures and sells medicine and pharmaceutical products in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
China Traditional Chinese Medicine
•
16 Aug 2024 01:05
TCM (570 HK): A Spoonful Of Sugar ...
Shares will pop today. Assuming payment late Dec, I'd buy up to HK$4.31/share, for a 7%/20% gross/annualised return. I wouldn't be too aggressive -...
David Blennerhassett
Follow
787 Views
Share
bullish
•
China Traditional Chinese Medicine
•
15 Aug 2024 17:32
China Traditional Chinese Medicine (570 HK): Relief as Update Favours the Bulls
The monthly update will relieve the bulls, but there remain potential stumbling blocks. Nevertheless, the risk vs. reward remains attractive.
Arun George
Follow
533 Views
Share
bullish
•
China Traditional Chinese Medicine
•
15 Aug 2024 10:55
TCM (570 HK): Where's The Floor?
With shares up 14.8% month-to-date, you kinda anticipated some positive developments were happening behind the scenes. Two articles came out this...
David Blennerhassett
Follow
951 Views
Share
bullish
•
China Traditional Chinese Medicine
•
11 Aug 2024 16:33
Merger Arb Mondays (12 Aug) - China TCM, Canvest, GA Pack, Fuji Soft, Fancl, Descente, Takiron
This week, the highest gross spreads are HEC Pharma (112.5%), China TCM (27.1%), Canvest (11.4%), Malaysia Airports (10.1%), Asia Cement China...
Arun George
Follow
439 Views
Share
bullish
•
China Traditional Chinese Medicine
•
28 Jul 2024 16:42
Merger Arb Mondays (29 Jul) - China TCM, Canvest, CPMC, GA Pack, Tohokushinsha, Furukawa, Tatsuta
This week, the highest gross spreads are HEC Pharma (126.8%), China TCM (37.3%), Canvest (11.9%), GAPack (11.8%), Asia Cement China (10.7%),...
Arun George
Follow
551 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.1
x